Heart device bleeding mystery unraveled in 500-Patient study
NCT ID NCT02628509
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study looked at how heart devices and treatments affect a blood protein called von Willebrand factor, which helps blood clot. Researchers studied 500 adults with advanced heart failure or aortic stenosis to understand when and why bleeding problems happen. The goal was to learn more about these risks, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lille University Hospital
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.